The Impact of Paravertebral Block Analgesia on Breast Cancer Survival after Surgery

Regional Anesthesia and Pain Medicine

Volumn 41, Issue 6, 2016, Pages 696-703

  Cata, Juan P ^a   Chavez Macgregor, Mariana ^a   Valero, Vicente ^a   Black, Walter ^a   Black, Daliah M ^a   Goravanchi, Farzin ^a   Ifeanyi, Ifey C ^a   Hernandez, Mike ^a   Rodriguez Restrepo, Andrea ^a   Gottumukkala, Vijaya ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; FENTANYL; HYDROMORPHONE; ISOFLURANE; OPIATE; REMIFENTANIL; SEVOFLURANE; SUFENTANIL; NARCOTIC ANALGESIC AGENT;

ADULT; AGE; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MODIFIED RADICAL MASTECTOMY; OVERALL SURVIVAL; PARAVERTEBRAL BLOCK ANALGESIA; PARTIAL MASTECTOMY; PATHOLOGY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; SIMPLE MASTECTOMY; SKIN SPARING MASTECTOMY; SURGICAL MORTALITY; ADVERSE EFFECTS; ANALGESIA; BREAST NEOPLASMS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NERVE BLOCK; PAIN, POSTOPERATIVE; PROCEDURES; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANALGESIA; ANALGESICS, OPIOID; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FENTANYL; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY; MIDDLE AGED; NERVE BLOCK; PAIN, POSTOPERATIVE; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84994239618     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0000000000000479     Document Type: Article

References (19)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7-30.
2. Habermann EB, Abbott A, Parsons HM, et al. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28:3437-3441.
3. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302: 1551-1556.
4. Sessler DI, Ben-Eliyahu S, Mascha EJ, et al. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials. 2008;29:517-526.
5. Forget P, Bentin C, Machiels JP, et al. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth. 2014;113 (suppl 1):i82-i87.
6. Retsky M, Demicheli R, Hrushesky WJ, et al. Reduction of breast cancer relapses with perioperative non-steroidal anti-inflammatory drugs: new findings and a review. Curr Med Chem. 2013;20:4163-4176.
7. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105:660-664.
8. Kairaluoma P, Mattson J, Heikkilä P, Pere P, Leidenius M. Perioperative paravertebral regional anaesthesia and breast cancer recurrence. Anticancer Res. 2016;36:415-418.
9. Starnes-Ott K, Goravanchi F, Meininger JC. Anesthetic choices and breast cancer recurrence: a retrospective pilot study of patient, disease, and treatment factors. Crit Care Nurs Q. 2015;38:200-210.
10. Cata JP, Zafereo M, Villarreal J, et al. Intraoperative opioids use for laryngeal squamous cell carcinoma surgery and recurrence: a retrospective study. J Clin Anesth. 2015;27:672-679.
11. Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3:900-908.
12. Goravanchi F, Kee SS, Kowalski AM, Berger JS, French KE. A case series of thoracic paravertebral blocks using a combination of ropivacaine, clonidine, epinephrine, and dexamethasone. J Clin Anesth. 2012;24: 664-667.
13. Cepeda MS, Boston R, Farrar JT, et al. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol. 2003;158:280-287.
14. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015; 34:3661-3679.
15. Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013;32:2837-2849.
16. Tsigonis AM, Al-Hamadani M, Linebarger JH, et al. Are cure rates for breast cancer improved by local and regional anesthesia? Reg Anesth Pain Med. 2016;41:339-347.
17. Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IVanesthesia for cancer surgery: a retrospective analysis. Anesthesiology. 2016;124:69-79.
18. Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016;69:126-132.
19. Beecher SM, O'Leary DP, McLaughlin R, et al. Influence of complications following immediate breast reconstruction on breast cancer recurrence rates. Br J Surg. 2016;103:391-398.